Depressive Symptoms and Amyloid Pathology.
JAMA Psychiatry. 2025;82(3):296-310 - PMID: 39841452 - PMCID: PMC11883504 - DOI: 10.1001/jamapsychiatry.2024.4305
Impaired Visuospatial Processing in Cerebral Visual Impairment Revealed by Performance on a Conjunction Visual Search Task.
Br J Vis Impair. 2023;42(3):587-598 - PMID: 39850325 - PMCID: PMC11756917 - DOI: 10.1177/02646196231187550
Selective use of ferumoxytol-enhanced magnetic resonance angiography in patients with renal insufficiency: insights from a pilot study.
Int J Cardiovasc Imaging. 2025;42(1):29-35 - PMID: 39870959 - DOI: 10.1007/s10554-025-03337-6
Indocyanine Blue (ICB) as a Functional Alternative to Indocyanine Green (ICG) for Enhanced 700 nm NIR Imaging.
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.
A specific and adaptable approach to track CD206+ macrophages by molecular MRI and fluorescence imaging.
Regional Variations in the Management of Cerebral Arteriovenous Malformations: A Nationwide Inpatient Sample Analysis of Surgical Excision and Endovascular Embolization.
J Clin Neurosci. 2025;133:110987 - PMID: 39778411 - DOI: 10.1016/j.jocn.2024.110987
Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup.
J Nucl Med. 2025;66(Suppl 2):S5-S31 - PMID: 39778970 - PMCID: PMC12794165 - DOI: 10.2967/jnumed.124.268756
Drug Development.
Alzheimers Dement. 2024;20 Suppl 6(Suppl 6):e085111 - PMID: 39782523 - PMCID: PMC11712541 - DOI: 10.1002/alz.085111
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e094128 - PMID: 39782872 - DOI: 10.1002/alz.094128
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093936 - PMID: 39782961 - DOI: 10.1002/alz.093936
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093920 - PMID: 39782985 - DOI: 10.1002/alz.093920
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093913 - PMID: 39783010 - DOI: 10.1002/alz.093913
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093683 - PMID: 39783095 - DOI: 10.1002/alz.093683
Alzheimer's Imaging Consortium.
Alzheimers Dement. 2024;20 Suppl 9:e093782 - PMID: 39783119 - DOI: 10.1002/alz.093782
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095635 - PMID: 39783135 - DOI: 10.1002/alz.095635
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095547 - PMID: 39783363 - DOI: 10.1002/alz.095547
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095630 - PMID: 39783408 - DOI: 10.1002/alz.095630
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e094824 - PMID: 39783465 - DOI: 10.1002/alz.094824
Developing Topics.
Alzheimers Dement. 2024;20 Suppl 8:e095237 - PMID: 39783725 - DOI: 10.1002/alz.095237
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e091824 - PMID: 39784074 - DOI: 10.1002/alz.091824
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e090893 - PMID: 39784207 - DOI: 10.1002/alz.090893
Public Health.
Alzheimers Dement. 2024;20 Suppl 7:e089624 - PMID: 39784818 - DOI: 10.1002/alz.089624
Public Health.
Alzheimers Dement. 2024;20 Suppl 7:e091037 - PMID: 39784872 - DOI: 10.1002/alz.091037
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e093205 - PMID: 39785302 - DOI: 10.1002/alz.093205
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e091415 - PMID: 39785462 - DOI: 10.1002/alz.091415
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e086293 - PMID: 39785544 - DOI: 10.1002/alz.086293
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e089927 - PMID: 39785619 - DOI: 10.1002/alz.089927
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e088686 - PMID: 39785734 - DOI: 10.1002/alz.088686
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e091078 - PMID: 39785826 - DOI: 10.1002/alz.091078
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e092759 - PMID: 39785936 - DOI: 10.1002/alz.092759
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e092812 - PMID: 39785940 - DOI: 10.1002/alz.092812
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e087431 - PMID: 39785982 - DOI: 10.1002/alz.087431
Biomarkers.
Alzheimers Dement. 2024;20 Suppl 2:e090828 - PMID: 39786140 - DOI: 10.1002/alz.090828
Contrastive Learning Approach for Assessment of Phonological Precision in Patients with Tongue Cancer Using MRI Data.
Interspeech. 2024;2024:927-931 - PMID: 39726638 - PMCID: PMC11671147 - DOI: 10.21437/interspeech.2024-2236
Quantifying articulatory variations across phonological environments: An atlas-based approach using dynamic magnetic resonance imaging.
J Acoust Soc Am. 2024;156(6):4000-4009 - PMID: 39670769 - PMCID: PMC11646136 - DOI: 10.1121/10.0034639
Elevated locus coeruleus metabolism provides resilience against cognitive decline in preclinical Alzheimer's disease.
DIFFUSION MODEL-BASED POSTERIOR DISTRIBUTION PREDICTION FOR KINETIC PARAMETER ESTIMATION IN DYNAMIC PET.
Proc IEEE Int Symp Biomed Imaging. 2024;2024:ePub - PMID: 39530051 - PMCID: PMC11554386 - DOI: 10.1109/isbi56570.2024.10635805
The Role of Imaging for Gastrointestinal Bleeding: Consensus Recommendations From the American College of Gastroenterology and Society of Abdominal Radiology.
Am J Gastroenterol. 2023;119(3):438-449 - PMID: 38857483 - DOI: 10.14309/ajg.0000000000002631
MRI in patients with inflammatory bowel disease.
J Magn Reson Imaging. 2011;33(3):527-34 - PMID: 21512607 - PMCID: PMC3078716 - DOI: 10.1002/jmri.22504
Sonographic findings of an adrenal leiomyosarcoma.
J Ultrasound Med. 2010;29(9):1369-73 - PMID: 20733196 - DOI: 10.7863/jum.2010.29.9.1369
Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer.
Cancer Res. 2024;84(15):2549-2560 - PMID: 38759082 - PMCID: PMC11293968 - DOI: 10.1158/0008-5472.CAN-23-3548
Granzyme B PET Imaging for Assessment of Disease Activity in Inflammatory Bowel Disease.
J Nucl Med. 2024;65(7):1137-1143 - PMID: 38754959 - PMCID: PMC11218731 - DOI: 10.2967/jnumed.123.267344
Diffusion Tensor Phenomapping of the Healthy and Pressure-Overloaded Human Heart.
Visuospatial processing in early brain-based visual impairment is associated with differential recruitment of dorsal and ventral visual streams.
The Pathophysiological Underpinnings of Gamma-Band Alterations in Psychiatric Disorders.
Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases.
Neurology. 2024;102(12):e209460 - PMID: 38815233 - PMCID: PMC11244748 - DOI: 10.1212/WNL.0000000000209460
Associations Between Self and Study Partner Report of Cognitive Decline With Regional Tau in a Multicohort Study.
Neurology. 2024;102(12):e209447 - PMID: 38810211 - PMCID: PMC11226320 - DOI: 10.1212/WNL.0000000000209447
Dynamics of collagen oxidation and cross linking in regenerating and irreversibly infarcted myocardium.
3 Tesla Fetal MR Imaging Quality and Safety Considerations.
Magn Reson Imaging Clin N Am. 2024;32(3):385-394 - PMID: 38944429 - DOI: 10.1016/j.mric.2024.02.007
703

